Daytime impairment during sleep restriction therapy for insomnia: Results from a randomised-controlled trial

Daytime impairment during sleep restriction therapy for insomnia: Results from a randomised-controlled trial

Section B. Clinical Sleep Science and Practice <br> Subsection I. Insomnia <br> Abstract: 0385

Opis bibliograficzny
Główni autorzy:	Maurer, LF, Espie, CA, Omlin, X, Kyle, SD
Format:	Conference item
Język:	English
Wydane:	Oxford University Press 2019

Podobne zapisy

Is restriction of time in bed central to the efficacy of sleep restriction therapy for insomnia? Results from a randomised, controlled, dismantling trial comparing sleep restriction with bedtime consistency
od: Maurer, LF, i wsp.
Wydane: (2019)

The effect of sleep restriction therapy for insomnia on sleep pressure and arousal: a randomised controlled mechanistic trial
od: Maurer, LF, i wsp.
Wydane: (2021)

Isolating the role of time in bed restriction in the treatment of insomnia: a randomised, controlled, dismantling trial comparing sleep restriction therapy with time in bed regularisation
od: Maurer, LF, i wsp.
Wydane: (2020)

The clinical effects of sleep restriction therapy for insomnia: a meta-analysis of randomised controlled trials
od: Maurer, LF, i wsp.
Wydane: (2021)

The acute effects of sleep restriction therapy for insomnia on circadian timing and vigilance
od: Maurer, LF, i wsp.
Wydane: (2020)

The acute effects of sleep restriction therapy for insomnia on circadian timing: a within-subjects evaluation of phase angle
od: Maurer, LF, i wsp.
Wydane: (2020)

Ecological momentary assessment of daytime symptoms during sleep restriction therapy for insomnia.
od: Miller, C, i wsp.
Wydane: (2013)

Ecological momentary assessment of daytime symptoms during sleep restriction therapy for insomnia
od: Miller, C, i wsp.
Wydane: (2013)

The effect of sleep restriction therapy for insomnia on REM sleep fragmentation: A secondary analysis of a randomised controlled trial
od: Maurer, L, i wsp.
Wydane: (2023)

Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder.
od: Kyle, S, i wsp.
Wydane: (2014)

Sham sleep feedback delivered via actigraphy biases daytime symptom reports in people with insomnia: Implications for insomnia disorder and wearable devices
od: Gavriloff, D, i wsp.
Wydane: (2018)

The effect of single‐component sleep restriction therapy on depressive symptoms: A systematic review and meta‐analysis
od: Tse, KYK, i wsp.
Wydane: (2024)

The mechanisms of sleep restriction therapy for insomnia disorder
od: Maurer, LF
Wydane: (2020)

The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey.
od: Espie, C, i wsp.
Wydane: (2012)

Improving sleep after stroke: a randomised controlled trial of digital cognitive behavioural therapy for insomnia
od: Fleming, MK, i wsp.
Wydane: (2023)

How does sleep restriction therapy for insomnia work? A systematic review of mechanistic evidence and the introduction of the Triple-R model
od: Maurer, L, i wsp.
Wydane: (2018)

Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial
od: Kyle, S, i wsp.
Wydane: (2017)

Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
od: Kyle, SD, i wsp.
Wydane: (2024)

The evidence base of sleep restriction therapy for treating insomnia disorder.
od: Miller, C, i wsp.
Wydane: (2014)

Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)
od: Kyle, S, i wsp.
Wydane: (2020)

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial
od: Kyle, S, i wsp.
Wydane: (2023)

O3 The effect of single-component sleep restriction therapy on depressive symptoms in individuals with insomnia: A systematic review and meta-analysis
od: Simon D Kyle, i wsp.
Wydane: (2023-10-01)

O6 Clinical effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care: a pragmatic, superiority, open-label, randomised controlled trial
od: Paul Aveyard, i wsp.
Wydane: (2023-10-01)

Nurse-delivered sleep restriction therapy in primary care for adults with insomnia disorder: a mixed-methods process evaluation
od: Armstrong, S, i wsp.
Wydane: (2023)

The effects of digital cognitive behavioural therapy for insomnia on cognitive function: a randomised, controlled trial
od: Kyle, SD, i wsp.
Wydane: (2020)

Insomnia prehabilitation in newly diagnosed breast cancer patients: Protocol for a pilot, multicentre, randomised controlled trial comparing nurse delivered sleep restriction therapy to sleep hygiene education (INVEST trial)
od: Fleming, L, i wsp.
Wydane: (2024)

Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial
od: Simon D. Kyle, i wsp.
Wydane: (2017-06-01)

No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia.
od: Kyle, S, i wsp.
Wydane: (2011)

Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial)
od: Paul Aveyard, i wsp.
Wydane: (2020-03-01)

Sleep and productivity benefits of digital cognitive behavioural therapy for insomnia: a randomised controlled trial conducted in the workplace environment
od: Bostock, S, i wsp.
Wydane: (2016)

"...Not just a minor thing, it is something major, which stops you from functioning daily": quality of life and daytime functioning in insomnia.
od: Kyle, S, i wsp.
Wydane: (2010)

The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: A meta-analysis and systematic review
od: Mitchell, L, i wsp.
Wydane: (2019)

The Burden of Sleep/Wake Disorders: Excessive Daytime Sleepiness and Insomnia Project
od: Marina Tüzün, i wsp.
Wydane: (2024-09-01)

Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
od: Simon D Kyle, i wsp.
Wydane: (2024-08-01)

Insomnia and daytime functioning problems
od: G. V. Kovrov, i wsp.
Wydane: (2013-12-01)

Psychometric properties of the Sleep Condition Indicator and Insomnia Severity Index in the evaluation of insomnia disorder
od: Wong, M, i wsp.
Wydane: (2016)

Psychological and behavioural interventions in bipolar disorder that target sleep and circadian rhythms: a systematic review of randomised controlled trials
od: Bisdounis, L, i wsp.
Wydane: (2021)

The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in Insomnia Disorder.
od: Kyle, S, i wsp.
Wydane: (2013)

The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in Insomnia Disorder.
od: Kyle, S, i wsp.
Wydane: (2013)

Effect of melatonin on insomnia and daytime sleepiness, in patients with obstructive sleep apnea and insomnia (COMISA): A randomized double-blinded placebo-controlled trial
od: Tahereh Madani Motlaq, i wsp.
Wydane: (2024-05-01)